Pivotal trial of MRI-guided transurethral ultrasound ablation (TULSA) of localized prostate cancer: 4-year follow-up
Pavlovich et al, AUA 2023 Annual Meeting (abstract MP73-05), The Journal of Urology (2023)
Pavlovich et al, AUA 2023 Annual Meeting (abstract MP73-05), The Journal of Urology (2023)
Klotz et al, The Journal of Urology (2021)
Hatiboglu et al, Frontiers in Oncology (2021)
Klotz et al, The Journal of Urology (2021)
Sundaram et al, Journal of Vascular and Interventional Radiology (2020)
Muschter et al, AUA 2023 Annual Meeting (abstract MP73-09) ,The Journal of Urology (2023)
Meyer et al, Urologia Internationalis (2023)
Miura et al, BJUI Compass (2022)
Kasraeian et al, WCET 2022 Annual Meeting (abstract MP20-14), Journal of Endourology (2022)
Busch et al, SIR 2022 Annual Scientific Meeting (Abstract No. 112), Journal of Vascular and Interventional Radiology (2022)
Lumiani et al, Urologic Oncology (2021)
Hatiboglu et al, JU Open Plus (2023)
Nair et al, BJU International (2020)
Nair et al, Scandinavian Journal of Urology (2020)
Bonekamp et al, European Radiology (2018)
CAUTION: Products shown may not be approved for sale in all jurisdictions. Rx only device.
Contact us at info@profoundmedical.com for more information regarding the regulatory status of the device.
106734B